Oxipit, a Lithuania-based medical imaging solutions manufacturer, and Healthcare Konnect, a Swiss distribution company, have announced a new partnership focused on delivering AI imaging solutions to Nigeria.

Amazon is signaling it may soon sell prescription drugs in the U.K., Canada and Australia after the company moved to trademark “Amazon Pharmacy” in those countries at the start of 2020, CNBC reported.

Deep learning-based reconstruction (DLR) can reduce the radiation dose associated with low-dose chest and abdominal CT scans without sacrificing image quality, according to a new study published in the American Journal of Roentgenology.

Some findings from AI in Healthcare’s 2020 Leadership Survey deserve additional attention.

More accountable care organizations are taking on downside financial risk in the Medicare Shared Savings Program than ever before, with 37% in the program today participating in these arrangements.

The concept of healthcare providers working with AI technologies still worries some patients.  

The Supreme Court won’t take up the ongoing appeal over the constitutionality of the Affordable Care Act, leaving the decision in the hands of a lower court.

The world could soon have a new most expensive drug if an experimental gene therapy for hemophilia patients could come in with a price tag between $2 million and $3 million is approved.

Unrecognized atrial fibrillation (AFib) is a significant issue, one that grows more and more common as time goes on.

For 2020, CVS Health has laid out a number of trends in the industry and several challenges to address, including chronic kidney disease care, social determinants of health, poverty and lack of healthcare access, and consumer preferences and engagement.